Armata Pharmaceuticals Inc (ARMP)
2.10
+0.01
(+0.48%)
USD |
NYAM |
Nov 21, 16:00
2.10
0.00 (0.00%)
After-Hours: 20:00
Armata Pharmaceuticals Shareholders Equity (Quarterly): -50.97M for Sept. 30, 2024
Shareholders Equity (Quarterly) Chart
Historical Shareholders Equity (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2024 | -50.97M |
| June 30, 2024 | -46.10M |
| March 31, 2024 | -56.51M |
| December 31, 2023 | -32.06M |
| September 30, 2023 | -12.39M |
| June 30, 2023 | 19.14M |
| March 31, 2023 | 22.45M |
| December 31, 2022 | 36.08M |
| September 30, 2022 | 45.58M |
| June 30, 2022 | 53.29M |
| March 31, 2022 | 61.54M |
| December 31, 2021 | 25.40M |
| September 30, 2021 | 23.76M |
| June 30, 2021 | 28.62M |
| March 31, 2021 | 34.01M |
| December 31, 2020 | 18.86M |
| September 30, 2020 | 24.62M |
| June 30, 2020 | 29.64M |
| March 31, 2020 | 33.48M |
| December 31, 2019 | 14.59M |
| September 30, 2019 | 18.13M |
| June 30, 2019 | 22.63M |
| Date | Value |
|---|---|
| March 31, 2019 | 4.961M |
| December 31, 2018 | 8.474M |
| September 30, 2018 | 6.853M |
| June 30, 2018 | 8.339M |
| March 31, 2018 | 11.29M |
| December 31, 2017 | 7.731M |
| September 30, 2017 | 9.757M |
| June 30, 2017 | 9.861M |
| March 31, 2017 | 6.648M |
| December 31, 2016 | 9.723M |
| September 30, 2016 | 18.23M |
| June 30, 2016 | 21.48M |
| March 31, 2016 | 8.897M |
| December 31, 2015 | 12.71M |
| September 30, 2015 | 15.66M |
| June 30, 2015 | 13.09M |
| March 31, 2015 | -3.076M |
| December 31, 2014 | 3.437M |
| September 30, 2014 | 11.34M |
| June 30, 2014 | -9.021M |
| March 31, 2014 | -24.11M |
| December 31, 2013 | -22.62M |
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
-56.51M
Minimum
Mar 2024
61.54M
Maximum
Mar 2022
13.65M
Average
24.19M
Median
Shareholders Equity (Quarterly) Benchmarks
| AIM ImmunoTech Inc | 2.912M |
| Perspective Therapeutics Inc | 328.47M |
| Protalix BioTherapeutics Inc | 32.44M |
| Electromed Inc | 41.49M |
| Xtant Medical Holdings Inc | 45.72M |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 98.24M |
| Total Liabilities (Quarterly) | 149.21M |